Ratings by Oppenheimer (Kevin DeGeeter)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/13/2023 | AN2 Therapeutics | ANTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2023 | AN2 Therapeutics | ANTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2022 | AN2 Therapeutics | ANTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2022 | Rezolute | RZLT | Maintain | (N/A) |
|
Details | ||
| 4/19/2022 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 4/19/2022 | AN2 Therapeutics | ANTX | New Coverage | Outperform (N/A) |
14.79 (2.40) |
-83.77% | Details | |
| 4/1/2022 | Taysha Gene Therapies | TSHA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2022 | Infinity Pharmaceutical | INFI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2022 | Sera Prognostics Inc | SERA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2022 | ORIC Pharamceuticals | ORIC | Downgrade | Perform (Outperform) |
6.78 (8.08) |
19.17% | Details | |
| 3/2/2022 | DermTech Inc. | DMTK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/2/2022 | NovoCure Ltd. | NVCR | Upgrade | Outperform (Perform) |
71.79 (12.34) |
-82.81% | Details | |
| 1/25/2022 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2021 | Sera Prognostics Inc | SERA | New Coverage | Outperform (N/A) |
11.22 (10.04) |
-10.52% | Details | |
| 9/30/2021 | Spero Therapeutics | SPRO | Downgrade | Perform (Outperform) |
18.18 (1.42) |
-92.19% | Details | |
| 9/21/2021 | Portage Biotech inc. | PRTG | New Coverage | Outperform (N/A) |
19.30 (0.25) |
-98.7% | Details | |
| 9/20/2021 | Personalis | PSNL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/31/2021 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/24/2021 | Humanigen | HGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2021 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/29/2021 | Bionano Genomics | BNGO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/29/2021 | Sensei Biotherapeutics | SNSE | Downgrade | Perform (Outperform) |
10.95 (0.99) |
-90.96% | Details | |
| 5/27/2021 | Rezolute | RZLT | New Coverage | Outperform (N/A) |
7.69 (2.89) |
-62.42% | Details | |
| 5/14/2021 | 9 Meter Biopharma | NMTR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2021 | Humanigen | HGEN | New Coverage | Outperform (N/A) |
19.02 (0.04) |
-99.79% | Details | |
| 5/6/2021 | Personalis | PSNL | Upgrade | Outperform (Perform) |
21.64 (1.30) |
-93.99% | Details | |
| 4/30/2021 | Cyclacel Pharmaceuticals | CYCC | New Coverage | Outperform (N/A) |
7.23 (2.30) |
-68.19% | Details | |
| 4/15/2021 | Molecular Templates | MTEM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/12/2021 | Taysha Gene Therapies | TSHA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/7/2021 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/5/2021 | Invitae Corporation | NVTA | Upgrade | Outperform (Perform) |
39.19 (0.02) |
-99.95% | Details | |
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2021 | Spero Therapeutics | SPRO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2021 | DermTech Inc. | DMTK | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2021 | Evaxion Biotech | EVAX | New Coverage | Outperform (N/A) |
7.08 (4.13) |
-41.67% | Details | |
| 3/1/2021 | Sensei Biotherapeutics | SNSE | New Coverage | Outperform (N/A) |
16.50 (0.99) |
-94% | Details | |
| 2/25/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2021 | Infinity Pharmaceutical | INFI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2021 | Orchard Therapeutics | ORTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/8/2021 | Bionano Genomics | BNGO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2021 | Infinity Pharmaceutical | INFI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2021 | Moleculin Biotech | MBRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2021 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2021 | Invitae Corporation | NVTA | Downgrade | Perform (Outperform) |
50.93 (0.02) |
-99.96% | Details | |
| 1/29/2021 | 9 Meter Biopharma | NMTR | New Coverage | Outperform (N/A) |
1.11 (0.07) |
-93.69% | Details | |
| 1/22/2021 | DermTech Inc. | DMTK | New Coverage | Outperform (N/A) |
43.75 (0.61) |
-98.61% | Details | |
| 1/13/2021 | Vascular Biogenics Ltd | VBLT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2021 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/11/2021 | Vericel Corporation | VCEL | Downgrade | Perform (Outperform) |
36.17 (46.11) |
27.48% | Details | |
| 1/5/2021 | Spero Therapeutics | SPRO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/5/2021 | Taysha Gene Therapies | TSHA | New Coverage | Outperform (N/A) |
26.54 (2.35) |
-91.15% | Details | |
| 12/31/2020 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/28/2020 | Cellectar Biosciences | CLRB | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2020 | Rocket Pharmaceuticals | RCKT | Downgrade | Perform (Outperform) |
32.08 (23.63) |
-26.34% | Details | |
| 11/6/2020 | Personalis | PSNL | Downgrade | Perform (Outperform) |
26.38 (1.30) |
-95.07% | Details | |
| 11/5/2020 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2020 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/22/2020 | Rocket Pharmaceuticals | RCKT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/14/2020 | Orchard Therapeutics | ORTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/20/2020 | Fulgent Genetics | FLGT | New Coverage | Outperform (N/A) |
44.01 (20.74) |
-52.87% | Details | |
| 8/17/2020 | Personalis | PSNL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Molecular Templates | MTEM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/27/2020 | Bionano Genomics | BNGO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2020 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2020 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/1/2020 | Rocket Pharmaceuticals | RCKT | New Coverage | Outperform (N/A) |
18.81 (23.63) |
25.62% | Details | |
| 6/1/2020 | NovoCure Ltd. | NVCR | New Coverage | Outperform (N/A) |
67.43 (12.34) |
-81.7% | Details | |
| 6/1/2020 | Orchard Therapeutics | ORTX | New Coverage | Outperform (N/A) |
9.50 (16.70) |
75.79% | Details | |
| 6/1/2020 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
56.21 (42.45) |
-24.48% | Details | |
| 5/12/2020 | Novavax | NVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2020 | Molecular Templates | MTEM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | PolarityTE | PTE | Downgrade | Perform (Outperform) |
1.09 (0.24) |
-77.98% | Details | |
| 4/17/2020 | Vascular Biogenics Ltd | VBLT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2020 | Bionano Genomics | BNGO | New Coverage | Outperform (N/A) |
0.28 (0.76) |
171.43% | Details | |
| 4/2/2020 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2020 | Personalis | PSNL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2020 | PolarityTE | PTE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2020 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2019 | Athenex | ATNX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2019 | Personalis | PSNL | Maintain | Outperform (N/A) |
|
Details | ||
| 10/17/2019 | Moleculin Biotech | MBRX | New Coverage | Outperform (N/A) |
1.02 (4.35) |
326.47% | Details | |
| 10/17/2019 | Ideaya Biosciences | IDYA | New Coverage | Outperform (N/A) |
6.50 (39.85) |
513.08% | Details | |
| 10/2/2019 | Spero Therapeutics | SPRO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2019 | Novavax | NVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/21/2019 | PolarityTE | PTE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2019 | PolarityTE | PTE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2019 | Infinity Pharmaceutical | INFI | New Coverage | Outperform (N/A) |
1.69 (0.04) |
-97.63% | Details | |
| 6/27/2019 | Vascular Biogenics Ltd | VBLT | New Coverage | Outperform (N/A) |
1.19 (0.16) |
-86.55% | Details | |
| 6/6/2019 | Cidara Therapeutics | CDTX | New Coverage | Outperform (N/A) |
1.52 (12.29) |
708.55% | Details | |
| 5/13/2019 | Novavax | NVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2019 | Vericel Corporation | VCEL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2019 | Athenex | ATNX | New Coverage | Outperform (N/A) |
9.88 (0.20) |
-97.98% | Details | |
| 4/8/2019 | PolarityTE | PTE | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2019 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/29/2019 | PolarityTE | PTE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2019 | Novavax | NVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2019 | Vericel Corporation | VCEL | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/1/2019 | Novavax | NVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2019 | Neon Therapeutics | NTGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2019 | Vericel Corporation | VCEL | New Coverage | Outperform (N/A) |
17.30 (46.11) |
166.53% | Details | |
| 1/29/2019 | PolarityTE | PTE | New Coverage | Outperform (N/A) |
17.00 (1.09) |
-93.59% | Details | |
| 1/4/2019 | Catalyst Biosciences | CBIO | New Coverage | Outperform (N/A) |
8.25 (0.51) |
-93.82% | Details | |
| 1/4/2019 | Neon Therapeutics | NTGN | New Coverage | Outperform (N/A) |
5.05 (3.07) |
-39.21% | Details | |
| 12/19/2018 | Genomic Health Inc. | GHDX | New Coverage | Perform (N/A) |
65.97 (63.44) |
-3.84% | Details | |
| 12/19/2018 | Invitae Corporation | NVTA | New Coverage | Outperform (N/A) |
11.00 (0.02) |
-99.82% | Details | |
| 12/11/2018 | Molecular Templates | MTEM | New Coverage | Outperform (N/A) |
4.39 (1.64) |
-62.64% | Details | |
| 12/11/2018 | BioTime, Inc. | BTX | New Coverage | Outperform (N/A) |
1.34 (0.21) |
-84.33% | Details | |
| 12/11/2018 | Novavax | NVAX | New Coverage | Outperform (N/A) |
2.05 (4.15) |
102.44% | Details |
